Elevance Health/$ELV
1D1W1MYTD1Y5YMAX
Capital at risk
About Elevance Health
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
- Ticker
- $ELV
- Sector
- Health
- Primary listing
- NYSE
- Employees
- 96,615
- Headquarters
- Indianapolis, United States
- Website
- www.elevancehealth.com
Elevance Health Metrics
BasicAdvanced
$87B
17.89
$22.47
0.68
$6.86
1.71%
Price and volume
Market cap
$87B
Beta
0.68
52-week high
$436.24
52-week low
$274.84
Average daily volume
961K
Dividend rate
$6.86
Financial strength
Current ratio
1.518
Quick ratio
1.374
Long term debt to equity
68.12
Total debt to equity
68.953
Dividend payout ratio (TTM)
30.36%
Interest coverage (TTM)
5.29%
Profitability
EBITDA (TTM)
8,324
Gross margin (TTM)
25.99%
Net profit margin (TTM)
2.47%
Operating margin (TTM)
3.79%
Effective tax rate (TTM)
15.61%
Revenue per employee (TTM)
$2,080,000
Management effectiveness
Return on assets (TTM)
3.83%
Return on equity (TTM)
11.13%
Valuation
Price to earnings (TTM)
17.886
Price to revenue (TTM)
0.44
Price to book
1.94
Price to tangible book (TTM)
15.67
Price to free cash flow (TTM)
14.057
Free cash flow yield (TTM)
7.11%
Free cash flow per share (TTM)
28.593
Dividend yield (TTM)
1.71%
Forward dividend yield
1.71%
Growth
Revenue change (TTM)
6.27%
Earnings per share change (TTM)
-3.90%
3-year revenue growth (CAGR)
6.67%
10-year revenue growth (CAGR)
9.40%
3-year earnings per share growth (CAGR)
-5.08%
10-year earnings per share growth (CAGR)
10.02%
3-year dividend per share growth (CAGR)
7.51%
10-year dividend per share growth (CAGR)
10.40%
What the Analysts think about Elevance Health
Analyst ratings (Buy, Hold, Sell) for Elevance Health stock.
Analyst projections of the future price of Elevance Health stock.
Bulls say / Bears say
Elevance Health posted a Q2 2026 adjusted EPS of $7.45, exceeding the IBES consensus estimate of $6.21 per share and demonstrating strong cost management (TradingView/Reuters)
The company raised its FY 2026 adjusted EPS guidance to at least $27.00 and reaffirmed its confidence in returning to at least 12% adjusted EPS growth in 2027, underscoring its robust earnings outlook (SEC)
Carelon segment revenue grew 6% year-over-year to $19.2 billion in Q2 2026, driven by scaling of risk-based solutions and increased pharmacy benefit management revenue, highlighting successful diversification beyond core insurance operations (SEC)
The Centers for Medicare & Medicaid Services threatened to suspend enrollment in Elevance’s Medicare Advantage prescription drug plans over alleged risk-adjustment data non-compliance, creating a significant regulatory overhang (Reuters)
Elevance’s adjusted operating margin contracted to 3.6% in Q2 2026 from 5.0% a year earlier, reflecting mounting margin pressure and triggering investor concern (Investing.com)
The benefit expense ratio rose 80 basis points year-over-year to 89.7% in Q2 2026, driven by elevated medical cost trends in government-sponsored segments, eroding profitability (SEC)
Data summarised monthly by Lightyear AI. Last updated on 20 Aug 2026.
Elevance Health Financial Performance
Revenues and expenses
Elevance Health Earnings Performance
Company profitability
Upcoming events
Elevance Health News
AllArticlesVideos
Funds containing Elevance Health
AllEURUSDGBP
Fund name | Fund size | $ELV weighting |
|---|---|---|
iShares S&P 500 Health Care Sector€IUHE | €125M | 1.39% |
iShares MSCI World Health Care Sector Advanced€CBUF | €606M | 1.34% |
iShares MSCI USA SRI$SUAS | $3.4B | 0.58% |
iShares MSCI USA SRI€QDVR | €2.9B | 0.58% |
iShares MSCI USA SRI£SUUS | £2.5B | 0.58% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.